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a b s t r a c t
Biologically produced 3-hydroxypropionic acid (3HP) is a potential source for sustainable acrylates and
can also ﬁnd direct use as monomer in the production of biodegradable polymers. For industrial-scale
production there is a need for robust cell factories tolerant to high concentration of 3HP, preferably at
low pH. Through adaptive laboratory evolution we selected S. cerevisiae strains with improved tolerance
to 3HP at pH 3.5. Genome sequencing followed by functional analysis identiﬁed the causal mutation in
SFA1 gene encoding S-(hydroxymethyl)glutathione dehydrogenase. Based on our ﬁndings, we propose
that 3HP toxicity is mediated by 3-hydroxypropionic aldehyde (reuterin) and that glutathione-
dependent reactions are used for reuterin detoxiﬁcation. The identiﬁed molecular response to 3HP
and reuterin may well be a general mechanism for handling resistance to organic acid and aldehydes by
living cells.
& 2014 International Metabolic Engineering Society Published by Elsevier Inc. On behalf of International
Metabolic Engineering Society. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
The carboxylic acid, 3-hydroxypropionic acid (3HP) is a poten-
tial platform chemical, which can be converted to a variety of
valuable products such as acrylic acid, 1,3-propanediol, malonic
acid, and building blocks for biodegradable polymers. Acrylic acid-
derived products are used in diverse applications including super-
absorbent polymers used in baby diapers and incontinence pro-
ducts, detergent polymers, various plastics, coatings, adhesives,
elastomers, and paints. To date the market for acrylic acid and
acrylic esters is around USD12 billion and it is predicted to grow at
a rate of 3.7% annually. Acrylic acid has traditionally been derived
from petrochemical feedstocks. Through fermentation with meta-
bolically engineered microorganisms 3HP may be produced from
renewable carbon sources, and further 3HP dehydration into
acrylic acid represents an attractive alternative to the traditional
acrylic acid production. Several methods for microbial production
of 3HP have been developed during the last ten years (Kumar et al.,
2013), where the most successful examples for 3HP production use
Escherichia coli and Klebsiella pneumonia as the hosts and glucose
and/or glycerol as substrates (Gokarn et al., 2007; Liao et al., 2010;
Suthers and Cameron, 2006; Valdehuesa et al., 2013). We have
developed baker‘s yeast, Saccharomyces cerevisiae, as an alternative
host for 3HP production as this allows executing the process at low
pH hereby ensuring direct production of 3HP acid (pKa 4.51)
instead of salt, which makes the process more economically
attractive (Chen et al., 2014).
The potential of microbial 3HP production has not yet been
fully realized, as product toxicity represents a major bottleneck for
industrial-scale production. Warnecke et al. (2008) applied multi-
SCale Analysis of Library Enrichments (SCALES) approach (Lynch et
al., 2007) and identiﬁed several genes and media supplements that
individually or in combination were found to improve ﬁtness of
E. coli grown in continuous ﬂow selections with increasing levels
of 3HP . Based on the SCALES approach, 3HP toxicity was proposed
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to be related to inhibition of the chorismate and threonine super-
pathways (Warnecke et al., 2010). Warnecke et al. (2012) also
identiﬁed a small open reading frame in E. coli K12 (called iroK)
encoding a 21-amino-acid peptide, which conferred 3HP tolerance.
Despite the extensive research in E. coli, there have been no
reports on improving 3HP tolerance in S. cerevisiae. Furthermore,
the toxicity mechanism of 3HP is not understood at the mole-
cular level.
One of the strategies to generate tolerance to speciﬁc chemicals
and environmental stresses is laboratory evolution here referred
to as adaptive laboratory evolution, which can result in genetic
changes that are difﬁcult if not impossible to predict rationally
(Dragosits and Mattanovich, 2013). With recent progress in syn-
thetic biology and in deep whole genome re-sequencing, it is
possible to investigate the links between genotype and phenotype,
and hereby the causal mutations in the evolved tolerant phenotypes
can be identiﬁed and reverse engineered in the host (Dhar et al.,
2011; Hong and Nielsen, 2012; Hong et al., 2011; Oud et al., 2012).
The aim of this work was to improve 3HP tolerance in yeast
and to understand the mechanisms underlying 3HP toxicity and
tolerance. Our strategy was to use adaptive laboratory evolution to
generate 3HP tolerance and then to decipher the mechanism for
3HP tolerance by combination of whole-genome re-sequencing
and transcriptome analysis to identify the relevant mutations that
contribute to the phenotypic changes.
2. Material and methods
2.1. Strains and growth conditions
The yeast and bacterial strains used in this study are listed in
Table S2. S. cerevisiae CEN.PK strains were obtained from Peter
Kötter (Johann Wolfgang Goethe-University Frankfurt, Germany)
and E. coli MG1655 was kindly provided by Adam Feist (University
of California, San Diego). CEN.PK113-7D was used as a reference
and a starting strain for the adaptive evolution approach, whereas
CEN.PK113-32D was used as a parent strain for genetic engineer-
ing. Other yeasts and E. coli strains were used for studying the
effect of glutathione (GSH) on 3HP tolerance. All standard cloning
was carried out using E. coli strain DH5α.
Yeast strains were maintained on yeast peptone dextrose (YPD)
medium at 30 1C for S. cerevisiae and at 25 1C for other yeast strains.
E. coli strains were maintained on Luria-Bertani (LB) medium at
37 1C. E. coli transformants were selected on LB medium containing
100 mg ml1 ampicillin. Growth test experiments for yeast and E. coli
were performed in deﬁned mineral medium and M9 medium,
respectively. The composition of deﬁned mineral medium was
previously described (Jensen et al., 2014). For every 1 l of medium,
159 ml of 0.5 M citrate solution and 41 ml of 1 M Na2HPO4 solution
were added into the concentrated deﬁned mineral medium to
maintain the pH at 3.5. For medium containing 3HP, the 3HP solution
(ca. 30% in water, Tokyo Chemical Industry Co.) was neutralized with
solid NaOH (0.133 g NaOH/1 ml of 3HP solution) and sterile-ﬁltered
before adding to the medium. Standard YPD and synthetic complete
(SC) drop-out media were prepared from pre-mixed powders from
Sigma-Aldrich. Most of the chemicals were obtained, if not indicated
otherwise, from Sigma-Aldrich.
2.2. Adaptive evolution of CEN.PK113-7D
Three 3HP-tolerant strains were generated from CEN.PK 113-7D
by a stepwise evolution approach for 200 generations on deﬁned
mineral medium (pH 3.5) containing 3HP. Speciﬁcally, a single colony
of CEN.PK113-7D was inoculated into 5 ml YPD and grown with
200 rpm, overnight at 30 1C. The overnight culture was diluted in
50 ml fresh YPD to obtain the ﬁnal OD600 of 0.5 and further
incubated at 200 rpm, 30 1C for 5 h. The cells obtained from 50 ml
YPD were used to inoculate three independent 250-ml shake ﬂasks
with bafﬂes containing 20 ml of the same medium and supplemen-
ted with 25 g l1 3HP to an initial OD600 of 0.1. The adaptive
evolution was carried out at 200 rpm, 30 1C until the exponential
phase was reached and the cells were transferred to new fresh
media. After the growth rate of the cultures has increased (E50
generations), the concentration of 3HP was increased to 50 g l1 and
the strains were further evolved for 34 days. Finally, ten single clones
were isolated from each last shake ﬂask and their growth rate on
mediumwith 50 g l1 3HP was measured. As all the clones from the
same evolution line showed identical behavior, we selected one clone
from each evolution line for further characterization.
2.3. Physiological characterization of evolved strains
Batch cultivation of evolved strains was performed in biological
triplicates on deﬁned mineral medium (pH 3.5) with or without
50 g l1 3HP. Pre-cultures were prepared by inoculating a single
colony from evolved and reference strains in 5 ml deﬁned mineral
medium (pH 3.5) and incubated at 200 rpm, 30 1C. After 24 h, the
pre-cultures were inoculated into a 250-ml shake ﬂask with bafﬂes
containing 40 ml of the same medium to a starting OD600¼0.01.
Batch cultivations of evolved strains grown on medium containing
50 g l1 3HP were performed as previously described except that
pre-cultures were grown on medium containing 10 g l1 3HP. As the
reference strain could not grow on 50 g l1 3HP, the batch cultiva-
tions were performed on medium containing 10 g l1 3HP instead.
Batch cultivations were carried out in an orbital shaking incubator at
200 rpm and 30 1C. Cell growth was determined by measuring the
absorbance at 600 nmwavelength. Glucose and primary metabolites
were quantiﬁed using and Ultimate 3000 HPLC (Dionex, Sunnyvale,
CA, USA) equipped with an Aminex HPX-87H ion exclusion column
(300 mm7.8 mm, Bio-Rad Laboratories, Hercules, CA, USA) at
60 1C, using 5 mM H2SO4 as the mobile phase at a ﬂow rate of
0.6 ml min1. Detection was performed using a Waters 410 Differ-
ential Refractometer Detector at 45 1C (Millipore Corp., Milford, MA),
and a Waters 486 Tunable Absorbance Detector set at 210 nm.
2.4. Whole genome sequencing of 3HP evolved strains
The genomic DNA of evolved strainswas isolated using QIAGEN Blood
& Cell Culture DNA Kit (QIAGEN) according to the manufacturer‘s
recommendation.Whole genome sequencingwas performed on Illumina
MiSeq at Science for Life Laboratory, KTH Royal Institution of Technology,
Sweden. The DNA library for genome sequencing was prepared with the
TruSeq DNA sample preparation kits and sequenced multiplexed in one
300-cycle run on an Illumina MiSeq, producing a total of 6.81 million
assignable 2150 bp read pairs. The raw reads were processed with
the FastqMcf tool (http://code.google.com/p/ea-utils) in order to remove
adapters and to clip poor quality ends (quality score o20). Reads shorter
than 50 bp after processing were discarded. The quality of the proces-
sed datawas evaluated using FastQC (http://www.bioinformatics.bbsrc.ac.
uk/projects/fastqc/) and passed all tests. Reads were mapped to the
reference genome (CEN.PK 113-7D, http://cenpk.tudelft.nl) with Mosai-
kAligner 2.1.32 (http://code.google.com/p/mosaik-aligner/) using a hash
size of 11 bp. Indels were located and realigned with RealignerTarget-
Creator/IndelRealigner of Genome Analysis Toolkit (GATK) (McKenna
et al., 2010). Duplicates were removed with the MarkDuplicates program
of the Picard package (http://picard.sourceforge.net). Single nucleotide
variants (SNVs) and small indels were detected using both GATK Uniﬁed
Genotyper and Samtools mpileup/vcftools (Danecek et al., 2011; Li et al.,
2009). The variant lists were ﬁltered for all variants detected as homo-
zygous for an alternative allele (different from the reference genome) in
one or more of the samples. A total of 51 variants showed the exact same
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variant in all four samples, and were discarded as errors in the reference
sequence. The remaining 24 variants were manually inspected with
Savant Genome Browser (Fiume et al., 2012), in order to discard obvious
false positives. Large structural variation was detected from the mapped
data using CNVnator 0.2.5 (Abyzov et al., 2011) and SVseq 2.0.1 (Zhang
et al., 2012). A denovo approach was also performed where individual
denovo assemblies were created with ABySS 1.3.4 (Simpson et al., 2009)
and analyzed with the approach and helper scripts of the SOAPsv
pipeline (Li et al., 2011). All methods found a number of structural var-
iants present in all samples, caused by the incomplete or incorrect refer-
ence sequence (usually in repeated regions). All potential variants were
inspected using the “Read Pair (Arc)” display mode of Savant Genome
Browser.
2.5. Transcriptome analysis
Samples for RNA isolation were taken from the mid-expo-
nential phase by rapidly sampling 25 ml of culture into a pre-
chilled 50 ml tube with crushed ice. Cells were immediately
centrifuged at 4 1C, 4000 rpm for 5 min. The supernatant was
discarded and the pellets were resuspended in 2 ml of RNAlaters
Solution (Ambion, Life Technologies) and incubated on ice for 1 h.
The cells were pelleted by centrifugation at 12,000g, few seconds.
The supernatant was discarded and the pellet was frozen in liquid
nitrogen, and stored at 80 1C until further analysis. Total RNA
extraction was performed using RNeasys Mini Kit (QIAGEN). After
thawing the samples on ice, 600 ml of buffer RLT containing 1% (v/
v) β-mercaptoethanol was added directly to the cells. The mixture
was transferred into a 2 ml extraction tube containing 500 ml glass
beads. The cells were disrupted twice in the PRECELLYSs24 (Bertin
Technologies) for 20 s at 6500 rpm. The cell mixture was pelleted
and the supernatant was transferred to a new tube and total RNA
was puriﬁed according to the manufacturing‘s protocol. The DNA
was removed from the RNA samples using Turbo DNA-free™ Kit
(Ambion). The quantity and quality of the RNA samples were
measured using NanoPhotometer (Implen) and Agilent 2100
Bioanalyzer using the RNA 6000 Nano Assay (Agilent Technolo-
gies), respectively. The RNA samples were stored at 80 1C.
Transcriptome data was generated at the Center for Biological
Sequence Analysis, Technical University of Denmark. cDNA synth-
esis and labeling were carried out according to Low Input Quick
Amp Labeling Kit (One-color) manual (Agilent). Hybridization was
performed using the NimbleGen Arrays containing probes for 5777
S. cerevisiae genes (Roche) and scanning with the NimbleGen MS
200 Microarray scanner.
The pre-processing and statistical analysis of the array data
was performed in the R statistical environment. The pdInfoBuilder
and oligo packages were applied for primary data handling
and pre-processing, where the Robust Multichip Average (RMA)
method was chosen for normalization and calculation of log 2
transformed expression indices. The org.Sc.sgd.db package, which
is primarily based on ORF identiﬁers from SGD, was used to
annotate the 5777 S. cerevisiae genes.
The gene expression values were compared between the refer-
ence strain (Ref) and each the four other conditions, Refþ3HP,
evo1, evo2, and evo3, and the signiﬁcance of differential expres-
sion for each gene was assessed by the t-test, as implemented in
the geneﬁlter package, followed by Benjamini & Hochberg P-value
correction. Furthermore mean log 2 fold changes between the
gene expression intensities for the four conditions (Refþ3HP, evo1,
evo2, and evo3), and the gene intensities for the Ref were calc-
ulated for each gene. Additionally a consensus gene list was com-
piled based on the P-values for the three independent evolutions.
Here the Fisher P-value combination method was used to deter-
mine a consensus P-value, and a consensus log fold change value
was calculated as the mean of the log fold changes for the three
independent evolutions. For each four conditions (Refþ3HP, evo1,
evo2, and evo3), as well as for the consensus list, a set of top genes
was deﬁned as the top signiﬁcant genes with a P-value less than
0.01 and absolute log fold change above 1.
The R gene set analysis package piano (version 1.2.10) (Väremo
et al., 2013) was used to calculate the enrichment of GO-slim terms
(Saccharomyces Genome Database, December 11, 2013) to be either
distinctively up or down regulated in Refþ3HP, evo1, evo2, and
evo3. The consensus P-values were used as gene-level statistics and
log 2 fold changes were used as gene-level statistics and directions,
respectively. The median (of the P-value gene-level statistics) was
chosen as a gene-set statistic. Other suitable gene-set statics yielded
qualitatively similar results. The signiﬁcance of enrichment was
determined via gene randomization and P-values were adjusted for
multiple testing using the false discovery rate (‘fdr’ option).
2.6. Plasmids and strains construction
The plasmids and primers used in this study are listed in Tables
S2 and S3, respectively. Manipulation of plasmid DNA and trans-
formation of plasmids into E. coli were carried out according to
standard procedures. Transformation of yeast cells was carried out
according to Gietz and Woods, 2002 (Gietz and Woods, 2002).
The sfa1Δ and ach1Δ strains were constructed by replacing the
target gene in the CEN.PK113-32D strain with the KanMX cassette. The
gene fragments carrying the KanMX cassette and correct overhangs for
SFA1 and ACH1 replacement were generated by PCR ampliﬁcation
using primers and templates as indicated in Table S3. The knock-out
fragment was transformed into S. cerevisiae and transformants were
selected on YPDþ200 mgml1 G418 and conﬁrmed by PCR.
The SFA1-alleles and YJL068Cwere ampliﬁed from genomic DNA of
S. cerevisiae using primers and templates as described in Table S3. The
ampliﬁed products were cloned together with promoter into pESC-
LEU-USER plasmid by USER cloning (Jensen et al., 2014). The clones
with correct inserts were conﬁrmed by sequencing. The ﬁnal plasmids
were then transformed into different yeast strain backgrounds (Ref,
ach1Δ, and sfa1Δ) and selected on synthetic complete medium
without leucine (SC-Leu). The resulting strains are listed in Table S2.
The strain with SFA1 allele replacement was constructed by
replacing the KanMX cassette in the sfa1Δ strain with the corr-
esponding upstream and downstream using the gene targeting
strategy (Reid et al., 2002). The upstream fragment including the
SFA1 allele for each SFA1 mutations, the downstream fragment of
SFA1 gene, the two fragments containing the 2/3 N-terminal and
the C-terminal 2/3 part of a Kluyveromyces lactis LEU2 (KlLEU2)
marker were ampliﬁed using primers described in Table S3. To
generate a complete gene targeting substrate, the upstream
fragment including the SFA1 allele for each SFA1 mutations was
fused to the 2/3 C-terminal of KlLEU2 using primers described in
Table S3. Similarly, the downstream fragment was fused to the
2/3 N-terminal of KlLEU2. The two fusion PCR fragments were co-
transformed into the sfa1Δ strain and selected SC-Leu medium.
The correct transformants were conﬁrmed by PCR and the muta-
tion in the SFA1 gene was veriﬁed by sequencing. For the control
strain, the SFA1wt allele was introduced back to the sfa1Δ strain in
an analogous way as other SFA1 alleles.
The PCR site-directed mutagenesis was performed to replace the
Cys276 residue with Gly, Ala, Val or Thr, and to replace the Met283
residue with Val or Ala using primers and templates listed in Table S3.
The ampliﬁed products were treated with DpnI, gel-puriﬁed and
subsequently transformed into E. coli. The correct mutations in the
SFA1 gene in the resulting plasmids were conﬁrmed by sequencing.
The SFA1 alleles were introduced back into the sfa1Δ strain as
previously described with a slightly modiﬁcation. Speciﬁcally, the
upstream part of gene targeting substrate was generated by fusion
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PCR using the SFA1 upstream, the SFA1-allele and the 2/3 C-
terminal of KlLEU2 fragments as templates.
2.7. Modeling of Sfa1p
We built a homology model of Sfa1p using the HHpred server
(http://toolkit.lmb.uni-muenchen.de/hhpred; PMID 15980461). The
model was based on the experimental structure of Arabidopsis
thaliana S-nitrosoglutatione reductase (3UKO), which exhibits 61%
sequence identity to Sfa1p and covers residue 4-384 (of 386 residues;
98.4%). Following homology modeling, two zinc ions and a NAD(P)þ
moiety were manually added from the template structure. The
covalently linked substrate intermediate (S-(3-hydroxypropanoyl)-
glutathione) was built by extending the corresponding substrate
(S-hydroxymethl-glutathione) taken from the structure of human
glutathione-dependent formaldehyde dehydrogenase (1MC5, PMID
12484756). The substrate intermediate was manually docked into the
model (in a conformation similar to that found in 1MC5) and the
entire complex was energy-minimized using the SYBYL software
package. Finally, the monomer Sfa1p model was duplicated and
arranged as a dimer by alignment to the template structure.
2.8. Growth test in 96-well microtiter plates
Pre-cultures were prepared by inoculating a single colony in 0.5 ml
deﬁned mineral medium (pH 3.5) containing 10 g l1 3HP in 96-deep
well plate (Enzyscreen). The plate was incubated at 30 1C with
250 rpm agitation at 5 cm orbit cast overnight. 5 ml of the overnight
cultures were inoculated into 100 ml of the same medium with or
without 50 g l1 3HP in a 96-well ﬂat bottom plate (Greiner). The
plate was sealed with Breathe-Easys sealing membrane (Sigma-
Aldrich) and incubated at 30 1C with shaking in the Synergy™ MX
microplate reader (BioTek) and the absorbance was measured at
600 nm wavelength every 15 min for 42 h. Experiments were done
in triplicates, and the speciﬁc growth rate (h1) was calculated.
The effect of different pH values (pH 3.0–6.0) on the robustness of
the 3HP-tolerant strains was performed by determining the maximal
speciﬁc growth rate of the strains on deﬁned mineral medium
buffered with citrate–phosphate buffer. Experiments were set up as
described above and were done in triplicates. To test whether
mutation in the SFA1 could confer tolerance to other compounds,
the strains with or without overexpression of SFA1 alleles were
grown in deﬁned mineral medium containing acetic acid (0–0.8%),
lactic acid (0–4%), furfural (0–20 mM), methanol (0–30%), 1-propanol
(0–15%), and 1-butanol (0–4%). For media containing acetic acid and
lactic acid, the pH was adjusted to 3.5 instead of pH 6.0. The effect of
GSH addition on 3HP tolerance in S. cerevisiae was performed by
determining the growth of the strains on deﬁned mineral medium
(pH 3.5) with addition of 50 g l1 3HP and various concentrations of
GSH (0–20 mM). The effect of GSH addition (5 mM) on the growth of
other yeast strains in the presence of 50 g l1 3HP was performed as
previously described except that deﬁned mineral medium (pH 6.0)
was used and the experiment was done at 25 1C. The effect of GSH
addition on the growth of ﬁve E. coli strains in the presence of
20 g l1 3HP was investigated as following: a single colony from each
strain was inoculated into 3 ml M9 medium and incubated at
250 rpm, 37 1C. 2 ml of the overnight cultures were used to inoculate
150 ml of M9, M9þ20 g l1 3HP, and M9þ20 g l1 3HP and 5 mM
GSH in 96-well ﬂat bottom plate. The pH of tested media was
adjusted to pH 7.0. The 96-well plate was incubated with shaking in
the ELx808™ Absorbance microplate reader (BioTek) at 37 1C and the
absorbance was measured at 630 nm wavelength every 5 min for
22 h. Experiments were done in triplicates.
2.9. LC-MS analysis
Intracellular metabolites were extracted from cells by adding
1 ml of 0.1% (v/v) formic acid in water directly to the cells and the
mixture was sonicated for 15 min. The cell mixture was pelleted
and the supernatant was ﬁltered through 0.2 mm syringe ﬁlter
into a HPLC vial for further analysis. LC-MS data was collected on
Orbitrap Fusion equipped with a Dionex brand Ultimate 3000
UHPLC pumping system (ThermoFisher Scientiﬁc, Waltham Ma).
Samples were held in the autosampler at a temperature of 10 1C
during the analysis. 25 ml injections of the sample were made onto
a Discovery HS F5-5 HPLC column, with a 5 mm particle size,
4.6 mm i.d. and 150 mm long. The column was held at a tempera-
ture of 30.0 1C. The solvent system used was Solvent A “Water
with 0.1% formic acid“ and Solvent B “Acetonitrile with 0.1%
formic“. The Flow Rate was 0.6 ml/min with an Initial Solvent
composition of %A¼95, %B¼5 held until 2.0 min, the solvent
composition was then changed following a Linear Gradient until
it reached %A¼0.0 and %B¼95 at 12 min. This was held until
14 min when the solvent was returned to the initial conditions and
the column was re-equilibrated until 20 min. The column eluent
ﬂowed directly into the Heated ESI probe of the MS which was
held at 325 1C and a voltage of 3500 V. Proﬁle Data was collected
in positive ion mode with Resolution setting of 30 K and Scan
Range (m/z)¼50–600. The other MS settings were as follows,
Sheath Gas Flow Rate of 60 units, Aux Gas Flow Rate of 20 units,
Sweep Gas Flow Rate of 5 units, Ion Transfer Tube Temp was
380 1C, Maximum Injection Time of 100 ms, S-Lens RF Level¼60 V,
using 1 Microscans and AGC Target¼200,000 counts. The data was
analyzed in a non-targeted manner using deconvolution software
(AnalyzerPro, SpectralWorks Ltd, UK).
3. Results
3.1. Adaptive laboratory evolution of S. cerevisiae on 3HP and the
resulting physiological and transcriptional changes
The growth of S. cerevisiae strain CEN.PK 113-7D is halved in the
presence of 25 g l1 3HP and abolished when more than 40 g l1
3HP is added (Fig. S1). Using serial shake ﬂask transfers for 48 days
(E200 generations) we obtained three parallel evolved cell lines
capable of growing in deﬁned mineral medium at pH 3.5 and a 3HP
concentration of 50 g l1 (Fig. 1A and B). Individual clones were
isolated from the end-point cultures of the three independent
evolution lines and designated as evo1, evo2 and evo3. The
maximum speciﬁc growth rate mmax at pH 3.5 and at 3HP concen-
tration of 50 g l1 was 0.18 h1 for evo1 and evo2 and 0.20 h1 for
evo3 (Fig. S2), while in the absence of 3HP the mmax was 0.33 h1,
which is comparable to the mmax of the reference strain. Two of the
evolved strains, evo1 and evo3, could not metabolize ethanol and
acetate after the exhaustion of glucose. In the presence of 3HP,
acetate production was signiﬁcantly increased in all three evolved
strains compared to the reference. By HPLC measurement it was
conﬁrmed that the yeast strains were not capable of metabolizing
3HP, as concentrations of 3HP remained unchanged during the
cultivation. Furthermore, the reference or evolved strains were
unable to grow on 3HP as the sole carbon source (data not shown).
Genome-wide transcription analysis was performed on the
three evolved strains and the Piano package for R (Väremo et al.,
2013) was used to assess the enrichment of GO-slim terms in
transcriptional changes. The evolved strains exposed to 50 g l1 of
3HP showed a clear separation from the reference strain exposed
to 3HP (10 g l1) in their transcriptional proﬁles (Fig. 1D). Inter-
estingly a handful of genes involved in response to oxidative stress
(e.g. AHP1, YPR1, GLR1, GSH1, GRE3 etc.) were only differentially
expressed in the evolved strains, indicating that these genes might
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be directly involved in the 3HP tolerance mechanism acquired
during the adaptive evolution.
3.2. Mutations in S-(hydroxymethyl)glutathione dehydrogenase
(SFA1) and CoA-transferase (ACH1) were found in the three evolved
cell lines by genome Re-sequencing
The genomes of the three evolved strains were sequenced and
mapped against the genome of the parent strain CEN.PK113-7D.
Remarkably, two genes (SFA1 and ACH1) contained non-silent
mutations in all three evolved strains. The strains evo1 and evo3
had the same single point mutation in SFA1, where nucleotide at
position 827 was changed from G to C (leading to a change in
amino acid sequence: Cys276Ser), whereas a different point
mutation, G849A (Met283Ile at the amino acid level) was observed
in evo2 (Fig. 1C). Mutations in ACH1 were different in the three
evolved strains: a large deletion in evo1, a point mutation
Cys347Gly in evo2 and a novel stop codon at position 488 in
evo3. The onset and propagation of the different mutations in SFA1
and ACH1 in the populations of strains were analyzed by Sanger
sequencing of SFA1 and ACH1 genes ampliﬁed from the inter-
mediate populations sampled throughout evolution (Fig. 1C). The
mutation in SFA1 occurred in evo3 earlier than in the other strains,
namely after 5 days of evolution (E49 generations), in a medium
containing 25 g l1 3HP, whereas SFA1 was ﬁrst mutated in evo1
and evo2 after shift to higher 3HP concentration (50 g l1) which
occurred after 70–80 generations, at day 16–20 of evolution.
Unlike SFA1, all mutations in ACH1 occurred after the 3HP
concentration was increased. After the appearance of mutations,
a mixed population was observed for 25–70 generations (6–18
days) until the cells harboring the mutations predominated.
Six additional genes were found to carry mutations in only one
of the evolved cell lines (Table S1). No insertions, gene duplica-
tions or modiﬁcations in the non-translated regions of the genome
were found.
3.3. Functional analysis reveals that mutations in SFA1 are the main
cause of 3HP tolerance
The genes that were found to carry mutations in the evolved
strains made the basis for reverse metabolic engineering to obtain
a 3HP-tolerant strain. We individually overexpressed or deleted
the eight candidate genes in the reference strain and tested the
effect of the genetic change on 3HP tolerance. Overexpression was
performed by introducing an additional copy of the gene of
interest under the control of a strong constitutive promoter, i.e.
pTEF1. In addition to the overexpression of the native SFA1 gene,
overexpression of the mutated alleles was tested as well in the
reference, sfa1Δ and ach1Δ strains. Overexpression of any of the
SFA1 alleles enabled growth of the cells in the presence of 50 g l1
3HP (Fig. 2A) with mmax similar to that of the evolved strains. On
the other hand, neither overexpression of ACH1 gene (native and
mutant alleles), nor overexpression or deletion of the other gene
candidates identiﬁed from re-sequencing (Table S1) supported
growth in the presence of 50 g l1 3HP. Deletion of ACH1 abolished
growth on ethanol, explaining the phenotype of the evo1 and evo3
Fig. 1. Evolutionary proﬁle and changes in the phenotype, genotype and transcriptional proﬁle of the evolved strains (evo1, evo2, and evo3). (A) Overview of the adaptive
laboratory evolution procedure. (B) Phenotypic changes in the evolved strains: increased tolerance towards 3HP. Growth of cells sampled throughout evolution was tested in
triplicates and standard deviations (SD) are shown by error bars. (C) Genotypic changes in the evolved strains. (D) Gene set enrichment analysis of evolved strains exposed to
50 g l1 3HP compare with the reference strain (Ref) exposed to 10 g l1 3HP. The Piano package for R was used to assess the enrichment of GO-slim terms in transcriptional
changes. The heat map shows the signiﬁcance of enrichment of GO-slim terms (process category) to be distinctively up-regulated i.e., containing predominantly positive
logarithmic fold changes. The matrix contains only terms with Po0.01 for at least one of the 3HP-treated strains and numbers in parentheses indicate total number of genes
in the set.
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strains that carried a large deletion and a novel stop codon in
ACH1, respectively. This is in agreement with the work previously
reported by Fleck and Brock (2009).
To investigate whether any of the SFA1 mutant alleles could
confer 3HP tolerance when expressed from the native promoter
rather than strong constitute promoter, the native SFA1 gene was
replaced by either SFA1C276S or SFA1M283I. The resulting strains had
shorter lag phase on 25 g l1 3HP than the strain with the SFA1wt
allele and they could grow on medium containing 3HP at con-
centrations above 40 g l1, whereas no growth was observed in
the strain carrying the native SFA1 allele (Fig. 2B). The effect of
different pH values on the robustness of 3HP-tolerant strains was
investigated. At 3HP concentration of 25 g l1, no signiﬁcant
difference in the robustness of the tolerant strains was observed
at pH values between 3.0 and 5.0 (Fig. S3A and 3B). However, in
medium containing 50 g l1 3HP, the growth inhibition was more
pronounced at pH 3.0 and pH 5.0 than at pH 3.5 and pH 4.0
(Fig. S3C). In addition, we also tested whether mutation in SFA1
could confer tolerance to other inhibitors, namely acetic acid, lactic
acid, furfural, methanol, 1-propanol, and 1-butanol. The SFA1
mutant alleles did not result in increased tolerance to any of the
tested compounds (data not shown).
3.4. 3D structure model of the Sfa1 protein
S-(hydroxymethyl)glutathione dehydrogenase encoded by SFA1
is a member of the class III alcohol dehydrogenase subfamily
(EC:1.1.1.284), which encompasses bi-functional enzymes contain-
ing both alcohol dehydrogenase and glutathione-dependent for-
maldehyde dehydrogenase activity. To investigate the structural
context of the mutations in SFA1 identiﬁed in the evolved strains,
we built a 3D structure model of Sfa1p based on an experimental
structure of A. thaliana S-nitrosoglutatione reductase, which is a
homo-dimer (3UKO) (Crotty, 2009). The model included a NADPþ
cofactor and a S-(3-hydroxypropanoyl)-glutathione ﬁtted in a
conformation similar to the one observed for the substrate in
human glutathione-dependent formaldehyde dehydrogenase
(1MC5). Each subunit contains two zinc-binding sites, one struc-
tural and one central to the catalytic function of the enzyme. An
overview of the model with the mutations discussed in this work
is shown in Fig. 2C. From the 3D model of Sfa1p it is evident that of
the two observed mutations one (Cys276Ser) is found in the
substrate-binding pocket interacting with the NADPþ cofactor on
the opposite side of the groove from the catalytic zinc, while the
other (Met283Ile) is centrally placed in the dimerization lobe of
the structure (approximately residues 268–326) in close proximity
of the binding groove. Given that these two mutations presumably
increase the ability of Sfa1p to accommodate and process the more
bulky 3HP, we hypothesized that substitutions, which expand the
substrate pocket, also increase the activity of Sfa1p towards 3HP.
Indeed, we found that replacement of Cys276 residue with other
small amino acids such as Thr, Gly, Val, Ala as well as replacing
Met283 with either Val or Ala also conferred the 3HP tolerance
phenotype (Fig. 2D).
Fig. 2. The effect of SFA1 on 3HP tolerance in yeast and characterization of Sfa1p. (A) 3HP tolerance in yeast conferred by overexpression of SFA1 alleles, pSFA1wt, pSFA1C276S, and
pSFA1M283I, compared with the reference (SFA1wt) and evolved strains (evo1, evo2, evo3) grown on deﬁned mineral medium (pH 3.5) with or without 50 g l1 of 3HP. (B) Growth
of strains carrying mutated SFA1C276S and SFA1M283I alleles, respectively, compared with the strain carrying the SFA1wt (analogous to WT) grown on medium containing 3HP
concentrations ranging from 0 to 50 g l1. Error bars represent the standard deviation (SD) in biological triplicates. (C) A 3D structure model of the Sfa1p from S. cerevisiae. The
residues in the two positions found to be mutated in the evolved strains are shown in light blue (positions 276 and 283). Residues in three adjacent positions are shown in darker
blue. The residue in position 313 reaches over (symmetrically) from the other subunit of the dimer (marked with an asterisk). The model also contains the NAD(P)þ cofactor
(purple) along with the putative, covalently linked substrate S-(3-hydroxypropanoyl)glutathione (HPG), consisting of a glutathione moiety (orange) and a 3-hydroxypropanoyl
moiety (green). (D) The effect of mutations in Cys276 and Met283 residues on 3HP tolerance. Growth characterization of each strain was performed in triplicates and SD is given
by error bars.
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3.5. Proposed glutathione-dependent 3-hydroxypropionic aldehyde
detoxiﬁcation mechanism
The function of Sfa1p in formaldehyde detoxiﬁcation has
been proposed previously (Wehner et al., 1993). Formaldehyde
spontaneously reacts with intracellular glutathione (GSH) to form
S-hydroxymethylglutathione, which is then converted into S-formylgl-
utathione by Sfa1p using NAD(P)þ as cofactor. We hypothesized that
in the yeast cells 3HP is converted into 3-hydroxypropionic aldehyde
(3HPA) by aldehyde dehydrogenases, and that it is 3HPA that causes
cellular toxicity and therefore has to be detoxiﬁed by a mechanism
analogous to that of formaldehyde detoxiﬁcation (Fig. 3).
In yeast the aldehyde dehydrogenases (Aldp) catalyze an impor-
tant reaction of converting acetaldehyde into acetate, which is
essential for generation of acetyl-CoA during growth on non-
fermentable carbon source (e.g. ethanol). These enzymes also take
care of oxidizing other harmful aldehydes (Yasokawa et al., 2010).
We proposed that the enzyme does also catalyze the reverse
reaction converting 3HP into 3HPA, which is supposedly highly
toxic to yeast. In aqueous solutions 3HPA is present as a mixture of
3HPA, HPA-hydrate and HPA-dimer in a dynamic equilibrium. This
mixture is generally referred to as reuterin, which is a wide-
spectrum antimicrobial compound, active against Gram positive
and Gram negative bacteria, fungi and protozoa (Axelsson et al.,
2009). It can therefore be an advantage for yeast cells to convert
reuterin into other less toxic compounds, and we here suggest that
this detoxiﬁcation involves spontaneous binding of 3HPA to GSH to
form S-(3-hydroxypropanoyl)glutathione, which is then oxidized
into S-(3-ketopropanoyl)glutathione by Sfa1p using NAD(P)þ as a
cofactor. Finally, the intermediate compound is hydrolyzed to 3HP
with release of GSH by the S-formylglutathione hydrolase (encoded
by YJL068C).
3.6. Deletion of ALD6 reduced susceptibility of yeast to 3HP
To investigate whether ALDs genes and their gene products are
involved in 3HP detoxiﬁcation mechanism, we tested the survival
of ALD single deletion strains on high concentrations of 3HP.
The ald deletion strains (ald2Δ, ald3Δ, ald4Δ, ald5Δ or ald6Δ)
together with their parental strain BY4741 were grown in a
medium containing either 25 or 50 g l1 3HP. No growth was
observed for any of the strains grown on 50 g l1 3HP. Growth of
the ald6Δ strain on 25 g l1 3HP was less inhibited by 3HP than
the growth of the reference strain (4% inhibition instead of 31%)
(Fig. 4A). These observations indicated a potential involvement of
ALDs genes in 3HP detoxiﬁcation and supported the proposed
detoxiﬁcation mechanism.
3.7. LC-MS analysis revealed that GSH involved in 3HP detoxiﬁcation
To further evaluate if GSH is involved in the 3HP detoxiﬁcation
mechanism we measured the intracellular GSH level in the cells
grown in a medium with or without 3HP by LC-MS analysis. The
intracellular GSH level was similar in all strains, when quantiﬁed
against the mass and retention time from an authentic glutathione
standard (Fig. S4). However, upon examination of the mass
spectral data ﬁles, we found groups of fragment ions that had
masses within 10 ppm, indicative of the presence of GSH adducts.
The identity of the GSH adducts could not be conﬁrmed because of
the lack of the standard. When relative quantitation (using the
peaks with m/z of 306) was carried out on these samples, we
observed a signiﬁcant increase (E250 fold) in the GSH adduct
concentration in the SFA1C276S-allele exposed to 50 g l1 3HP
compared to the reference strain (Fig. 4B). These results provide
strong evidence that GSH play an important role in 3HP detox-
iﬁcation by binding to 3HPA.
3.8. Glutathione supplementation improved 3HP tolerance in several
yeast species and in E. coli
Based on the proposed 3HP detoxiﬁcation mechanism, we
suggested that 3HP tolerance in S. cerevisiae might be improved by
increasing the availability of GSH either by external addition or by
improving its intracellular production. We therefore tested the effect
of addition of external GSH for improving 3HP tolerance by
S. cerevisiae. The strains with native or mutated SFA1 alleles or with
sfa1 deletion were grown with or without 50 g l1 3HP and supple-
mented with varying concentrations of GSH (0–20mM). The
Fig. 3. The proposed glutathione-dependent mechanism of 3HP detoxiﬁcation. Red circle indicates the reaction catalyzed by Sfa1p, an enzyme that carries mutations in the
evolved 3HP-tolerant strains.
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concentrations of GSH above 2.5 mM restored the growth of the S.
cerevisiae in the presence of 50 g l1 3HP so the μmax was slightly
higher than that of the SFA1-mutated strains grown without GSH
supplement (Fig. 4C). Furthermore, GSH addition also further
improved the growth rate of the strain carrying the SFA1C276S or
SFA1M283I alleles. The growth of the sfa1Δ strain could not be restored
by addition of GSH. In addition, GSH had no signiﬁcant effect on the
growth of the strains in the absence of 3HP. These ﬁndings further
conﬁrm the connection between tolerance to 3HP, GSH and Sfa1p.
In addition to S. cerevisiae, we demonstrated that addition
of GSH also improves the tolerance of several other yeast species
to 3HP. Addition of 5 mM GSH enabled growth of 3HP-sensitive
strains (S. cerevisiae, Saccharomyces kluyveri and K. lactis) in the
presence of 50 g l1 3HP and improved the μmax of the strains that
were naturally tolerant to 3HP (Kluyveromyces marxianus, Yarrowia
lipolytica, Cyberlindnera jadinii, Schizosaccharomyces pombe, Toru-
laspora delbrueckii and Rhodotorula minuta) (Fig. S5A). Similarly
supplementation of 5 mM GSH restored the growth of ﬁve E. coli
strains, i.e. W3110, CROOKS, W, DH5α and BL21, in M9 medium
supplemented with 20 g l1 3HP and improved the growth of
MG1655 strain (Fig. S5B). These results suggest that our identiﬁed
mechanism for improving tolerance to 3HP may be similar in
different microorganisms.
3.9. S-formylglutathione hydrolase is involved in 3HP detoxiﬁcation
In the proposed 3HP detoxiﬁcation pathway, we suggest that
the intermediate S-(3-ketopropanoyl)glutathione derived from
Sfa1p activity is further converted into 3HP by the S-form-
ylglutathione hydrolase encoded by YJL068C. Therefore, the role
of S-formylglutathione hydrolase in 3HP detoxiﬁcation was inves-
tigated. The YJL068C gene was either deleted or overexpressed in
strains expressing either native or SFA1 alleles and tested for 3HP
tolerance on medium containing 25 g l1 3HP. The concentration
of 25 g l1 3HP was used because the SFA1wt background strain
could not tolerate 50 g l1 3HP. Deletion of YJL068C gene dec-
reased μmax on 3HP by 55% in the strain with SFA1wt background
and by 10–20% in the strains with SFA1C276S or SFA1M283I (Fig. S6A).
Overexpression of YJL068C also had a negative effect on 3HP
tolerance, with 30% and 10% decrease in μmax in SFA1wt and
SFA1C276S backgrounds correspondingly (Fig. S6B). Deletion or
overexpression of YJL068C might affect the turnover rate of GSH
recycling and the overall detoxiﬁcation mechanism.
4. Discussion
In this study, we demonstrated that adaptive laboratory evolu-
tion is a powerful method to generate S. cerevisiae strains tolerant
to a heterologous product (3HP) and also to provide insights about
possible mechanism for product toxicity and detoxiﬁcation. By
re-sequencing the genomes of the evolved 3HP-tolerant strains we
found mutations in a total of 8 genes, of which SFA1 and ACH1
were mutated in all three evolved strain lines. By inverse meta-
bolic engineering we could reconstitute the 3HP-tolerant pheno-
type to the level of that of the evolved strains by overexpressing
SFA1 or by point-mutating SFA1 to substitute amino acids in
positions Cys276 or Met283 to smaller ones such as Gly, Ala or
Ile. It appeared that the expression level of the native SFA1 was
insufﬁcient to confer tolerance to 3HP. However the mutations
likely increased the activity of the enzyme towards the 3HP-
derived compound and hence even the native levels of the gene
expression were sufﬁcient for tolerance.
We hypothesized that 3HP can be converted in the yeast cells
into 3HPA by aldehyde dehydrogenases. Several hypotheses for
Fig. 4. Inﬂuence of aldehyde dehydrogenase and glutathione on 3HP tolerance in S. cerevisiae. (A) Growth characteristics of ALD deletion strains grown on SC medium with
or without 25 g l1 3HP. (B) LC-MS analysis of intracellular GSH adduct level from S. cerevisiae carrying the native (SFA1wt) or mutated SFA1 gene (SFA1C276S) grown on
deﬁned mineral medium (pH 3.5) with or without 3HP. Data represented as a fold change of GSH abundance relative to the SFA1wt strain (no 3HP). (C) The effect of GSH
addition on 3HP tolerance in S. cerevisiae carrying the SFA1-alleles and the sfa1Δ strain grown on medium containing 50 g l1 3HP. Error bars represent SD of biological
triplicates.
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toxicity of 3HPA have been proposed. The ability of the dimeric
form of 3HPA to act as competitive inhibitor of ribonucleotides
makes it an inhibitor of DNA synthesis that can lead to cell death.
Alternatively, 3HPA is highly reactive and can inhibit the activity of
thioredoxin, a protein participating in cellular redox regulation
(Barbirato et al., 1996; Rasch, 2002). Furthermore, 3HPA might
interact with thiol groups and primary amines and therefore could
inactivate proteins and small molecules containing these thiol
groups (Vollenweider and Lacroix, 2004). Recently, Schaefer et al.
(2010) provided the evidence that reuterin induces oxidative stress
in E. coli cells by modifying thiol groups of proteins and small
molecules. Gene expression analysis of E. coli in response to
exposure to reutein revealed an increased expression of genes that
encode proteins containing thiol groups and genes involved in the
oxidative stress response. In our case, gene expression analysis of
the evolved strains exposed to 3HP also revealed signiﬁcant
changes in genes involved in oxidative stress and redox balance,
which strongly indicated that the cells were undergoing oxidative
stress mediated by interaction of the aldehyde form of reuterin and
thiol groups of small molecules and proteins.
It has been reported that certain mutations in SFA1 or SFA1
deletion can decrease resistance to formaldehyde, S-nitrosoglu-
tathione, and peroxynitrite (Fernández et al., 2003). Other recently
reported mutations in the SFA1 gene (Val208Ile, Ala303Thr,
Met283Ile, Ile309Met, and Pro313Ala) have been shown to improve
formaldehyde tolerance (Zhang et al., 2013). Two of these mutations
(Val208Ile and Ala303Thr) are located in the active site of Sfa1p.
Interestingly, mutations Ala303Thr, Ile309Met, and Pro313Ala
(reaching over from the other monomer, Fig. 2C) form a tight
cluster around Met283 and thus seem to identify a mutational
hotspot with the ability to modulate the function of Sfa1p.
In our 3D model, both Cys276 and Met283 are located in the
vicinity of the substrate-binding pocket. By replacing these amino
acid residues with other smaller amino acids, Sfa1p apparently
becomes more efﬁcient at processing 3HPA. This suggests a
widening of the substrate-binding pocket, since 3HPA is signiﬁ-
cantly larger than formaldehyde. Other possibilities, which cannot
be ruled out based on our data include changes in enzyme
dynamics and thus active site accessibility or an increased rate of
release of the product (or cofactor) from the binding site due to
mild destabilization of the complex.
We were wondering whether some speciﬁc mutations in SFA1
gene are conserved among distantly related organisms. We there-
fore aligned Sfa1p orthologs from several yeast species, A. thaliana,
E. coli and Lactobacilli species, which naturally possess high
tolerance to reuterin (Fig. S7). Surprisingly, the position corre-
sponding to Sfa1p residue 276, was conserved across all the
analyzed Lactobacilli and contained Thr instead of Cys. Another
position, 283 was also conserved in Lactobacilli with Ile or Val.
Both E. coli and yeast had Met in position 283. These ﬁndings may
point towards the similarity for the mechanism of 3HPA tolerance
across different species. However, some yeast strains (i.e. C. jadinii,
S. pombe, T. delbrueckii, K. marxianus, Y. lipolytica and R. minuta) are
naturally tolerant to 3HP while they do not contain mutation in
the SFA1p. The robustness of these strains to high 3HP concentra-
tion might occur by other mechanism, where higher expression
level of the SFA1 gene or higher glutathione regeneration could be
some of the possibilities.
We observed that GSH could rescue or improve the growth of
several yeast species and of E. coli in the presence of 3HP. GSH plays
an important role in several stress response mechanisms such as
protection against oxidative stress, xenobiotics, and heavy metal
stress, and maintaining the cellular redox homeostasis (Carmel-Harel
and Storz, 2000; Meister and Anderson, 1983; Penninckx, 2002). We
proposed that GSH is involved in 3HPA detoxiﬁcation by trapping the
toxic 3HPA into S-(3-hydroxypropanoyl)glutathione, which can then
become the substrate for Sfa1p. It was previously reported that
several facultative anaerobic Gram positive bacteria (e.g. Lactococcus
lactis subsp. lactis, Streptococcus agalactiae ATCC 12927) and the
native reuterin producers such as L. reuteri can synthesize signiﬁcant
amount of GSH (Cleusix et al., 2007; Vollenweider et al., 2010).
The proposed 3HP tolerance mechanismwas quite different from
the common tolerance mechanism to weak organic acids. In general,
the toxicity of organic acids depends on their hydrophobicity and
pKa. At external pH below pKa, the equilibrium will move toward
the undissociated form (RCOOH), which can cross the cell mem-
brane by simple diffusion. Once inside the higher pH environment of
the cytosol, the acid will dissociate and generate protons and the
acid anion (RCOO). The acid anion cannot readily permeate across
the plasma membrane and will accumulate inside the cell, which
can interfere with several metabolic pathways and cause severe
oxidative stress (Casal et al., 2008). To overcome toxicity generated
by carboxylic acids, one could improve the secretion of carboxylic
acid to reduce anion accumulation. For example, enhancement of
acetic acid tolerance could be obtained by overexpressing HAA1
gene, a transcriptional activator of multiple membrane transporters
(Tanaka et al., 2012).
The effect of engineering 3HP tolerance into 3HP-producing yeast
strains is currently under investigation. We observed no negative
effect of overexpressing mutated alleles of SFA1 on 3HP production
(our unpublished results); however positive effects will likely ﬁrst be
seen at higher 3HP titers, preferably above 50 g l1.
5. Conclusion
This study shows how laboratory evolution, followed by func-
tional and systems-level analysis, enabled uncovering glutathione-
dependent mechanism behind 3HP detoxiﬁcation. Glutathione-
dependent detoxiﬁcation of 3HP was not limited to the studied
organism (S. cerevisiae), but was conserved across several yeast spp.
and E. coli. The tolerance to 3HP could be reverse engineered into
S. cerevisiae host, which is valuable for biological production of 3HP,
one of the most interesting building block chemicals for sustainable
polymer production. Finally our results suggest that 3HP toxicity
may be mediated by 3HPA (reuterin), an antimicrobial compound
important for maintaining healthy gut ﬂora in humans and animals.
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